🇺🇸 Triamcinolone Injection in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 3
Most-reported reactions
- Ocular Hypertension — 2 reports (66.67%)
- Neurogenic Bladder — 1 report (33.33%)
Other Immunology, Rheumatology, Dermatology approved in United States
Frequently asked questions
Is Triamcinolone Injection approved in United States?
Triamcinolone Injection does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Triamcinolone Injection in United States?
University of Miami is the originator. The local marketing authorisation holder may differ — check the official source linked above.